84 related articles for article (PubMed ID: 18489600)
1. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
[No Abstract] [Full Text] [Related]
2. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
[No Abstract] [Full Text] [Related]
3. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
4. [Sunitinib-induced pyoderma gangrenosum].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Dec; 140(12):841-2. PubMed ID: 24315238
[No Abstract] [Full Text] [Related]
5. Sunitinib induced pyoderma gangrenosum-like ulcerations.
Akanay-Diesel S; Hoff NP; Kürle S; Haes J; Erhardt A; Häussinger D; Schulte KW; Bölke E; Matuschek C; Budach W; Gerber PA; Homey B
Eur J Med Res; 2011 Nov; 16(11):491-4. PubMed ID: 22027642
[TBL] [Abstract][Full Text] [Related]
6. Acute severe hypothyroidism induced by sunitinib.
Prat A; Serrano C; Valverde C; Calvo E
Radiother Oncol; 2008 Oct; 89(1):124-5. PubMed ID: 18502526
[No Abstract] [Full Text] [Related]
7. Imatinib induced pyoderma gangrenosum.
Pinato DJ; Sharma R
J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
[No Abstract] [Full Text] [Related]
8. Sunitinib and Thrombosis.
Lamba G; Deol R; Shah D; Sahni R; Malhotra BK
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S128-30. PubMed ID: 21881834
[No Abstract] [Full Text] [Related]
9. Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib.
Saylor PJ; Reid TR
J Clin Oncol; 2007 Aug; 25(23):3544-6. PubMed ID: 17687160
[No Abstract] [Full Text] [Related]
10. Cardiotoxicity associated with sunitinib.
Hariharan S; Lowry S
Lancet; 2008 Apr; 371(9620):1244-5; author reply 1245. PubMed ID: 18406854
[No Abstract] [Full Text] [Related]
11. Summaries for patients. Underactive thyroid function after treatment with sunitinib for gastrointestinal cancer.
Ann Intern Med; 2006 Nov; 145(9):I44. PubMed ID: 17088575
[No Abstract] [Full Text] [Related]
12. Guillain-Barré syndrome after treatment with sunitinib malate?
Mulherin B; Loconte NK; Holen KD
Oncology (Williston Park); 2008 Jan; 22(1):66-7, 70-1. PubMed ID: 18251284
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib-induced pseudoporphyria.
Sanz-Motilva V; Martorell-Calatayud A; Llombart B; Requena C; Serra-Guillén C; Nagore E; Guillén C; Traves V; Sanmartín O
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1848-50. PubMed ID: 24813651
[No Abstract] [Full Text] [Related]
14. [Drug Interaction between Sutent (sunitinib) and Bi-spirogyl (spiramycin-metronidazol): risk of toxicity].
Trabelsi S; Boussen H; Gaïes E; Salouage I; El Aïdli S; Daghfous R; Loueslati MH; Lakhal M; Belkahia C
Therapie; 2008; 63(6):475-6. PubMed ID: 19374036
[No Abstract] [Full Text] [Related]
15. Pyoderma Gangrenosum Associated with Sunitinib: A Case Report.
Sevimli Dikicier B
Adv Skin Wound Care; 2019 Sep; 32(9):427-429. PubMed ID: 31408027
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib-induced pyoderma gangrenosum-like skin ulcer.
Kuntz T; Koushk-Jalali B; Kreuter A
CMAJ; 2020 May; 192(20):E552. PubMed ID: 32452467
[No Abstract] [Full Text] [Related]
17. Sunitinib: new drug. For some gastrointestinal stromal tumours.
Prescrire Int; 2007 Aug; 16(90):138-41. PubMed ID: 17724833
[TBL] [Abstract][Full Text] [Related]
18. Drug-Induced Pyoderma Gangrenosum: A Review.
Wang JY; French LE; Shear NH; Amiri A; Alavi A
Am J Clin Dermatol; 2018 Feb; 19(1):67-77. PubMed ID: 28624960
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib-induced scrotal cutaneous side-effect.
Chou CY; Wang KH; Lin YH; Lin YT; Tsai HH
J Dermatol; 2013 Jan; 40(1):67-8. PubMed ID: 23078345
[No Abstract] [Full Text] [Related]
20. Emphysematous cholecystitis in a patient with gastrointestinal stromal tumor treated with sunitinib.
de Lima Lopes G; Rocha Lima CM
Pharmacotherapy; 2007 May; 27(5):775-7. PubMed ID: 17461715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
